1 May 2025
Prof Robin Ali tells us how his new role as Academic Lead for Advanced Therapies at King's Health Partners culminates a long journey of developing effective gene and cell therapies, and will support the next generation of researchers.
The Life Lines project has now delivered more than 1,100 tablets to connect families with their loved ones through the COVID-19 pandemic.
A trial of a unique formulation of ibuprofen treatment for treating severe acute respiratory distress syndrome (ARDS) has launched.
Learn how virtual meetings and Mindapples’ wellbeing principles keep people with learning disabilities connected during lockdown.
We explore how King's Health Partners is working to ensure healthcare workers can access the support they need.
A partnership between King’s Health Partners’ organisations and 3D printing manufacturers is helping supply face shields for staff.
Dr Yijing Li, Lecturer in Urban Informatics at King’s College London, discusses the team effort crucial to our COVID-19 response.
Our Mind & Body team have launched their first Learning Disability Strategy to help bridge a 16-year mortality gap.
A new, free online resource exploring COVID-19’s impact on our wellbeing, mental health and coping strategies.
A new trial repurposing a blood cancer drug for patients with COVID-19 is being launched.
Researchers have found a common 'immune signature' in many of the sickest COVID-19 patients which could help guide treatment.
Learning Hub
Sign up to our newsletter
